Abstract
In order to better characterize the mechanisms which regulate the immune response at the pulmonary level, the effects of beta-interferon (IFN-beta) and lymphokines (LK) on prostaglandin E (PGE) release and the suppressive capacity of mouse resident alveolar (AM phi) and pleural macrophages (PlM phi) were investigated in comparison with peritoneal macrophages (PM phi). After in vitro exposure to IFN-beta, PlM phi and PM phi showed a significant decrease of suppressive capacity and PGE release, whereas LK treatment did not affect such activities. In contrast, pre-treatment of AM phi with LK caused a strong impairment of their suppressive capacity. This effect was optimal after an incubation time of 20 h, was evident also at very low doses of LK and was not paralleled by any change of PGE release. Again in contrast with PlM phi and PM phi, suppressive capacity of AM phi was decreased only by very high doses of IFN-beta, whereas lower doses caused either an increase or no change of this activity. Furthermore, PGE release by AM phi was markedly increased after treatment with IFN-beta. Thus, suppressive capacity of AM phi appears to be controlled by different mechanisms from those of PlM phi and PM phi. In addition, a dissociation is evident between suppressive capacity and PGE release by AM phi.
MeSH Terms
Animals
Ascitic Fluid/immunology
Cells, Cultured
Dose-Response Relationship, Immunologic
Immune Tolerance
Interferon Type I/pharmacology
Lymphocyte Activation
Lymphokines/pharmacology
Macrophages/immunology,metabolism
Male
Mice
Mice, Inbred C3H
Pleural Effusion/immunology
Prostaglandins E/biosynthesis
Pulmonary Alveoli/immunology
Chemicals
Interferon Type I
Lymphokines
Prostaglandins E
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Sestini P
Tagliabue A
Boraschi D
References (24)
24 references, click to expand
-
The J. Burns Amberson LECTURE The induction and expression of cell-mediated hypersensitivity in the lung.
Am Rev Respir Dis. 1971 Dec;104(6):813-28
PMID: 4942214
-
Interferon-gamma reduces macrophage-suppressive activity by inhibiting prostaglandin E2 release and inducing interleukin 1 production.
J Immunol. 1984 Aug;133(2):764-8
PMID: 6330202
-
Inhibitory activity of unstimulated alveolar macrophages on T-lymphocyte blastogenic response.
Am Rev Respir Dis. 1978 Oct;118(4):791-3
PMID: 309295
-
Hyporesponsiveness of canine bronchoalveolar lymphocytes to mitogens: inhibition of lymphocyte proliferation by alveolar macrophages.
J Immunol. 1979 Feb;122(2):542-8
PMID: 762434
-
Immunosuppressive activity of canine pulmonary surface active material.
J Immunol. 1979 Mar;122(3):1062-6
PMID: 156211
-
Suppressive effect of alveolar macrophages on the in vitro immune response of rabbit lymphocytes.
J Reticuloendothel Soc. 1979 May;25(5):495-512
PMID: 379328
-
The pulmonary-alveolar macrophage (second of two parts).
N Engl J Med. 1979 Sep 20;301(12):639-45
PMID: 381928
-
Macrophage-mediated suppression. I. Evidence for participation of both hdyrogen peroxide and prostaglandins in suppression of murine lymphocyte proliferation.
J Immunol. 1980 Feb;124(2):983-8
PMID: 7356724
-
Alveolar macrophage suppression of canine bronchoalveolar lymphocytes: the role of prostaglandin E2 in the inhibition of mitogen-responses.
J Immunol. 1980 Mar;124(3):1365-70
PMID: 7358985
-
Immunological function of alveolar macrophages: interaction with a soluble protein antigen and the immunogenicity of alveolar macrophage-associated antigen.
J Reticuloendothel Soc. 1980 Aug;28(2):111-27
PMID: 6967975
-
Immunoregulatory activity of double-stranded RNA (BRL 5907): effect of murine adherent peritoneal exudate cells on lymphocyte response.
J Reticuloendothel Soc. 1980 Oct;28(4):313-25
PMID: 6448925
-
Influence of various macrophage populations on Con-A induced T-cell proliferation.
Immunology. 1980 Oct;41(2):379-85
PMID: 6969220
-
Antigen-presenting function of alveolar macrophages: uptake and presentation of Listeria monocytogenes.
J Immunol. 1981 Feb;126(2):794-9
PMID: 6778924
-
Identification and initial characterization of a nonspecific suppressor factor (macrophage-SF) produced by soluble immune response suppressor (SIRS)-treated macrophages.
J Immunol. 1981 Nov;127(5):1828-33
PMID: 7197699
-
Mouse pleural macrophages: characterization and comparison with mouse alveolar and peritoneal macrophages.
J Reticuloendothel Soc. 1982 Mar;31(3):207-20
PMID: 7042971
-
The structural basis for immunity in the respiratory tract.
Int Rev Exp Pathol. 1982;23:47-112
PMID: 7045014
-
Macrophage activation by interferon: dissociation between tumoricidal capacity and suppressive activity.
Eur J Immunol. 1982 Apr;12(4):320-6
PMID: 6178603
-
Modulation of mitogen-induced proliferation of autologous peripheral blood lymphocytes by human alveolar macrophages.
Infect Immun. 1982 Oct;38(1):260-6
PMID: 6982862
-
Murine alveolar macrophage-mediated lymphocyte cytostasis: kinetics and mechanisms.
Cell Immunol. 1982 Nov 1;73(2):264-74
PMID: 6984361
-
Bronchoalveolar lavage cell--lymphocyte interactions in normal nonsmokers and smokers. Analysis with a novel system.
Am Rev Respir Dis. 1983 May;127(5):545-8
PMID: 6601923
-
A murine model of asbestosis.
Am J Pathol. 1983 Sep;112(3):326-37
PMID: 6311019
-
Interferon decreases production of hydrogen peroxide by macrophages: correlation with reduction of suppressive capacity and of anti-microbial activity.
Immunology. 1983 Nov;50(3):359-68
PMID: 6354920
-
Interferon inhibits prostaglandin biosynthesis in macrophages: effects on arachidonic acid metabolism.
J Immunol. 1984 Apr;132(4):1987-92
PMID: 6321595
-
Studies on the regulation of lymphocyte reactivity by normal and activated macrophages.
Cell Immunol. 1977 Apr;30(1):108-21
PMID: 67900